TY - JOUR
AU - T. S. Bartholomew
AU - M. Plesons
AU - D. P. Serota
AU - E. Alonso
AU - L. R. Metsch
AU - D. J. Feaster
AU - J. Ucha
AU - E. Suarez Jr.
AU - D. W. Forrest
AU - T. A. Chueng
AU - K. Ciraldo
AU - J. Brooks
AU - J. D. Smith
AU - J. A. Barocas
AU - H. E. Tookes
A1 - 
AD - Division of Health Services Research and Policy, Department of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14th St, Miami, FL, 33136, USA. Tsb61@miami.edu.; Division of Health Services Research and Policy, Department of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14th St, Miami, FL, 33136, USA.; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.; Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.; Biostatistics Division, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.; Department of Psychiatry, University of Miami Miller School of Medicine, Miami, FL, USA.; Department of Anthropology, University of Miami, Miami, FL, USA.; Department of Population Health Sciences, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA.; Divisions of General Internal Medicine and Infectious Diseases, Department of Internal Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
AN - 38528570
BT - Addict Sci Clin Pract
C5 - Opioids & Substance Use; Healthcare Disparities; HIT & Telehealth; Financing & Sustainability
CP - 1
DA - Mar 25
DO - 10.1186/s13722-024-00447-9
DP - NLM
ET - 20240325
IS - 1
JF - Addict Sci Clin Pract
LA - eng
PY - 2024
SN - 1940-0632 (Print); 1940-0632
SP - 21
ST - Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
T1 - Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
T2 - Addict Sci Clin Pract
TI - Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
U1 - Opioids & Substance Use; Healthcare Disparities; HIT & Telehealth; Financing & Sustainability
U3 - 10.1186/s13722-024-00447-9
VL - 19
VO - 1940-0632 (Print); 1940-0632
Y1 - 2024
ER -